The merger with the compliance and quality specialist company, Complya, enables PharmaLex to build on its existing FDA expertise
The PharmaLex Group, specialist provider of development consulting and scientific affairs, regulatory affairs and pharmacovigilance, has completed the merger of Complya Consulting Group.
The merger enables PharmaLex to build on its existing US FDA Quality and Compliance expertise; Complya's main area of work is GXP Quality Assurance services.
The company also provide a spectrum of related consulting services, including GCP/GLP/GMP Quality Assurance and Regulatory Affairs support.
Following this acquisition, PharmaLex now has one the largest US pools of experts supporting pharmaceutical and biotech companies with their health authority obligations.
Tilo Netzer, CEO PharmaLex, said: “We can now provide the complete spectrum of services to support the requirements of health authorities in all mature markets – from regulatory strategy to quality assurance services.”